Trade Report: Today, AstraZeneca plc (AZN) Receives “Hold” Rating from HSBC

Today, AstraZeneca plc (AZN) Receives “Hold” Rating from HSBC

HSBC restated their hold rating on shares of AstraZeneca plc (LON:AZN) in a research note released on Wednesday. The firm currently has a GBX 4,700 ($58.31) price target on the biopharmaceutical company’s stock.

AZN has been the topic of several other reports. JPMorgan Chase & Co. restated a neutral rating and set a GBX 4,900 ($60.79) price target on shares of AstraZeneca plc in a research report on Wednesday, October 26th. Societe Generale restated a buy rating and set a GBX 7,000 ($86.84) price target on shares of AstraZeneca plc in a research report on Wednesday, September 14th. Goldman Sachs Group Inc. restated a sell rating and set a GBX 4,000 ($49.62) price target on shares of AstraZeneca plc in a research report on Thursday, October 27th. Morgan Stanley lifted their price target on AstraZeneca plc from GBX 5,000 ($62.03) to GBX 5,800 ($71.95) and gave the company an overweight rating in a research report on Friday, August 19th. Finally, Deutsche Bank AG restated a buy rating and set a GBX 5,800 ($71.95) price target on shares of AstraZeneca plc in a research report on Wednesday, September 28th. Four analysts have rated the stock with a sell rating, fourteen have given a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of Hold and an average target price of GBX 4,958.40 ($61.51).

AstraZeneca plc (LON:AZN) opened at 4238.50 on Wednesday. AstraZeneca plc has a 1-year low of GBX 3,680.00 and a 1-year high of GBX 5,505.00. The company’s market cap is GBX 53.62 billion. The stock’s 50 day moving average price is GBX 4,592.74 and its 200 day moving average price is GBX 4,592.37.

Related posts

Leave a Comment